← All Passage Bio, INC filings

Passage Bio, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
PASG
Passage Bio, INC
DEF: Passage Bio Schedules 2026 Annual Meeting and Proxy Votes
Passage Bio has announced its 2026 virtual annual meeting to elect directors, ratify auditors, and conduct advisory votes on executive compensation.
NASDAQ
PASG
Passage Bio, INC
DEFA14A: Passage Bio, Inc. Announces 2025 Annual Meeting and Proxy Voting Details
Passage Bio, Inc. sets date for its 2025 Annual Meeting and encourages stockholders to vote on key proposals, including director elections, auditor ratification, and a potential reverse stock split.
NASDAQ
PASG
Passage Bio, INC
DEF: Passage Bio Seeks Stockholder Approval for Reverse Stock Split to Regain Nasdaq Compliance
Passage Bio is asking stockholders to approve a reverse stock split to boost its share price and maintain its Nasdaq listing.
NASDAQ
PASG
Passage Bio, INC
DEFA14A: Passage Bio, Inc. Sets Date for 2024 Annual Meeting, Outlines Voting Matters
Passage Bio, Inc. announces its 2024 Annual Meeting of Stockholders to be held virtually on May 21, 2024, outlining key proposals for shareholder voting.
NASDAQ
PASG
Passage Bio, INC
DEF 14A: Passage Bio, Inc. Sets Date for 2024 Annual Stockholders Meeting
Passage Bio, Inc. announces its 2024 Annual Meeting of Stockholders to be held virtually on May 21, 2024, to elect directors and ratify the appointment of KPMG LLP as its independent accounting firm.